New Perspectives in Tuberculosis Prevention and Control

Dear Colleagues,

Globally, tuberculosis remains a major public health concern, despite the progress made in reducing morbidity and mortality in the last two decades. The World Health Organization estimated that about 10.6 million patients had incident TB in 2022, a reduction of about 9% from what had been estimated in 2015. Although global and national TB programs are making the utmost efforts to meet the end TB target of reducing TB incidence by 80% by 2030 compared to 2015, with the current rate of reduction, this target looks far-fetched.

While there are several interventions proven to reduce the incidence of TB, their implementation remains suboptimal. There is a need to effectively implement interventions such as early diagnosis and treatment of patients for TB, infection prevention and control at health facilities, communities, and congregate settings, tuberculosis preventive therapy for high-risk groups, implementation of the multisectoral accountability framework, adult vaccination, and concentrated efforts on TB prevention in key and vulnerable groups. Any new perspectives on optimizing and effectively implementing the above interventions would help national TB programs to scale up these interventions in their countries. Thus, these new perspectives on TB prevention and control would help the global community meet the ambitious end of TB targets by 2035.

In this regard, we request that you submit your research work related to any of the interventions mentioned above to this Special Issue on “New perspectives in tuberculosis prevention and Control”. To ensure research uptake and cross-learning, this Special Issue will be widely circulated among researchers, academicians, and policymakers involved in TB control.

Dr. Pruthu Thekkur
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• tuberculosis infection
• early diagnosis
• tuberculosis treatment adherence
• tuberculosis preventive therapy
• adult vaccination for tuberculosis
• multisectoral accountability framework
• tuberculosis infection prevention and control
• end TB strategy
• key and vulnerable populations for TB
• operational research